Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination regimen used ...

The Fujifilm rumors are as reliable as a Japanese train at this point, with plenty of water cooler talk proving to be prescient. Fujifilm has confirmed that a successor to the Fujifilm X-Pro3 is in ...